Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > any thoughts

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon Jun 01, 2021 2:56pm

130 Views

Post# 33304378

RE:RE:RE:RE:RE:any thoughts

Amen brother, that's the thing no one is talking about. For you average diabetic, this infact could be a functional cure. Or even in pre-diabetes patients, this could prevent them from becoming diabetic. As far as I understand you cannot have too many islets in your body. It's a long road ahead, but again based on this abstract, everything is going very well on the science side.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December